Newsroom

Sorted by: Latest

-

Arcturus Therapeutics to Attend Upcoming Investor Conferences

SAN DIEGO--(BUSINESS WIRE)--Arcturus Therapeutics Holdings Inc. (the “Company”, “Arcturus”, Nasdaq: ARCT), a commercial messenger RNA medicine company focused on the development of infectious disease vaccines and opportunities within liver and respiratory rare diseases, today announced that the Company will participate in the following investor conferences: Jefferies Global Healthcare Conference (Presentation) Wednesday, June 4, 2025 (4:20 p.m. ET) Goldman Sachs Annual Global Healthcare Confere...
-

Robert Schriesheim Appointed Interim Chief Financial Officer of Skyworks

IRVINE, Calif.--(BUSINESS WIRE)--Skyworks Solutions, Inc. (Nasdaq: SWKS), an innovator of high-performance analog and mixed-signal semiconductors connecting people, places and things, announced today that Mark Dentinger will not be joining Skyworks as Chief Financial Officer (CFO) due to an unforeseen medical condition. Robert Schriesheim, a member of Skyworks’ Board of Directors, has been appointed interim CFO while Skyworks conducts a comprehensive search for a successor. “We were looking for...
-

NetApp Reports Record Results for Fourth Quarter and Fiscal Year 2025

SAN JOSE, Calif.--(BUSINESS WIRE)--NetApp (NASDAQ: NTAP), the intelligent data infrastructure company, today reported financial results for the fourth quarter and fiscal year 2025, which ended on April 25, 2025. “Fiscal Year 2025 marked many revenue and profitability records, driven by significant market share gains in all-flash storage and accelerating growth in our first party and marketplace storage services. During the year, we refreshed our entire systems portfolio, sharpened the focus of...
-

NYSE to Commence Delisting Proceedings Against Solo Brands, Inc.

NEW YORK--(BUSINESS WIRE)--The New York Stock Exchange (“NYSE”, the “Exchange”) announced today that the staff of NYSE Regulation has determined to commence proceedings to delist the Class A common stock of Solo Brands, Inc. (the “Company”) from the NYSE pursuant to Section 802.01B of the NYSE’s Listed Company Manual because the Company had fallen below the NYSE’s continued listing standard requiring listed companies to maintain an average global market capitalization over a consecutive 30 trad...
-

Experienced Lender Joins Menlo Dental Transitions as Practice Advisor for the Southeast

TEMPE, Ariz.--(BUSINESS WIRE)--After a successful dental lending career, Matt Adrian has joined Menlo Dental Transitions as a Practice Advisor....
-

Northwind Midstream Partners Announces Permitting of Third AGI Injection Well, Final Approval of MRV Plan, and the Completion of New Compressor Station

HOUSTON--(BUSINESS WIRE)--Northwind Midstream Partners LLC (“Northwind” or the “Company”) today announced that it has received a final order from the New Mexico Oil Conservation Commission approving an additional acid gas injection (“AGI”) and carbon sequestration well to be located at the Company’s Titan Treating Complex in Lea County, New Mexico. New Devonian AGI Well This will be Northwind’s third AGI well, increasing the Company’s total permitted daily injection capacity to ~37 million stan...
-

TIXiMED Announces Successful Completion of a Phase 1 Study of its Novel Oral Disease-Modifying Type 1 Diabetes Therapy

BIRMINGHAM, Ala.--(BUSINESS WIRE)--TIXiMED Announces Successful Completion of a Phase 1 Study of its Novel Oral Disease-Modifying Type 1 Diabetes Therapy, TIX100...
-

Gen Re Releases 2024 U.S. Group Term Life Market Survey Results

STAMFORD, Conn.--(BUSINESS WIRE)--Gen Re releases 2024 U.S. Group Term Life Market Survey results: Large growth in Group Term Life business....
-

Das Edison Histotripsy System von HistoSonics erhält in Großbritannien vorzeitigen Marktzugang aufgrund einer Genehmigung für ungedeckten klinischen Bedarf

MINNEAPOLIS--(BUSINESS WIRE)--HistoSonics gab heute bekannt, dass sein Edison Histotripsy System zur nicht-invasiven Zerstörung von Lebertumoren in Großbritannien im Rahmen einer Unmet Clinical Need Authorisation (UCNA) einen kontrollierten frühen begrenzten Marktzugang erhalten hat. Diese Zulassung, die im Rahmen des britischen Programms „Innovative Devices Access Pathway“ (IDAP) erteilt wurde, ermöglicht bestimmten Patienten mit Lebertumoren einen kontrollierten frühen Zugang zur Histotripsy...
-

28 Nexstar Television Stations Win 52 Regional Edward R. Murrow Awards for Outstanding Journalism and Exceptional Locally Produced News

IRVING, Texas--(BUSINESS WIRE)--Nexstar Media Group's owned and operated television stations have earned a total of 52 regional Edward R. Murrow Awards for outstanding local news....